Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5)

Molecular Endocrinology

Volumn 15, Issue 1, 2001, Pages 136-148

  Friedrichsen, Birgitte Nissen ^a   Galsgaard, Elisabeth Douglas ^a   Nielsen, Jens Høiriis ^a   Møldrup, Annette ^a,b  

^a HAGEDORN RESEARCH INSTITUTE   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DOXYCYCLINE; GENISTEIN; GROWTH HORMONE; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROLACTIN; PROLACTIN RECEPTOR; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; STAT5 PROTEIN; STAUROSPORINE; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HORMONAL REGULATION; INSULIN RELEASE; INSULINOMA; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANIMALIA; JANUS;

EID: 0035131009     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.15.1.0576     Document Type: Article

References (45)

1. Growth hormone is a growth factor for the differentiated pancreatic β-cell
2. The role of growth hormone and prolactin in β cell growth and regeneration
3. The stimulatory effect of growth hormone, prolactin, and placental lactogen on β-cell proliferation is not mediated by insulin-like growth factor-I
4. Rat insulinoma cells express both a 115-kDa growth hormone receptor and a 95-kDa prolactin receptor structurally related to the hepatic receptors
5. Effects of sex and pregnancy hormones on growth hormone and prolactin receptor gene expression in insulin-producing cells
6. Expression and regulation of growth hormone (GH) and prolactin (PRL) receptors in a rat insulin producing cell line (INS-1)
7. Structural design and molecular evolution of a cytokine receptor superfamily
8. Signaling via JAK tyrosine kinases: Growth hormone receptor as a model system
9. Identification of a growth hormoneresponsive STAT5-binding element in the rat insulin 1 gene
10. Regulation of prolactin receptor (PRLR) gene expression in insulinproducing cells. Prolactin and growth hormone activate one of the rat PRLR gene promoters via STAT5a and STAT5b
11. Molecular mechanism of growth hormone action
12. Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice
13. Glucose, other secretagogues, and nerve growth-factor stimulate mitogen-activated protein-kinase in the insulin-secreting β-cell line, INS-1
14. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: Signal transduction via Janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling
15. Identification of tyrosine residues in the intracellular domain of the growth hormone receptor required for transcriptional signaling and STAT5 activation
16. Tyrosine docking sites of the rat prolactin receptor required for association and activation of STAT5
17. Mutational analysis of the intracellular domain of the human growth hormone receptor
18. Intracellular tyrosine residues of the human growth hormone receptor are not required for the signaling of proliferation or JAK-STAT activation
19. Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors
20. Molecular mechanism of growth hormone signalling
21. STAT5 is required for IL-2-induced cell cycle progression of peripheral T cells
22. STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation
23. STAT5b is essential for natural killer cell-mediated proliferation and cytolytic activity
24. Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation
25. Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation
26. Constitutive activation of the JAK2/STAT5 signal transduction pathway correlates with growth factor independence of megakaryocytic leukemic cell lines
27. Transcriptional regulation of the cyclin D1 promoter by STAT5: Its involvement in cytokine-dependent growth of hematopoietic cells
28. Postreceptor signaling of growth-hormone and prolactin and their effects in the differentiated insulinsecreting cell-line INS-1
29. Deletion of the carboxyl-terminal transactivation domain of MGF- STAT5 results in sustained DNA binding and a dominant negative phenotype
30. Modulation of glucose responsiveness of insulinoma beta-cells by graded overexpression of glucokinase
31. Insulin-like-growthfactor-1 (IGF-1)-stimulated pancreatic β-cell growth is glucose-dependent - Synergistic activation of insulin-receptor substrate-mediated signal-transduction pathways by glucose and IGF-1 in INS-1 cells
32. Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in β (INS-1)-cells
33. Linking protein kinase C to cell-cycle control
34. The p38/reactivating kinase mitogen-activated protein kinase cascade mediates the activation of the transcription factor insulin upstream factor 1 and insulin gene transcription by high glucose in pancreatic β-cells
35. Negative regulation of the JAK/STAT pathway
36. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins
37. Prolactin regulation of islet-derived INS-1 cells: Characteristics and immunocytochemical analysis of STAT5 translocation
38. Growth hormone binding to specific receptors stimulates growth and function of cloned insulin-producing rat insulinoma RIN-5AH cells
39. Cyclin D3: Requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation
40. Induction of D2 and D3 cyclin-encoding genes during promotion of the G1/S transition by prolactin in rat Nb2 cells
41. Cloning and functional analysis of rat cyclin D2 promoter: Multiple prolactinresponsive elements
42. STAT5b inhibits NFκB-mediated signaling
43. Accelerated entry into S-phase associated with up-regulation of cyclin-D1 as a mechanism for granulocyte-colony-stimulatingfactor (G-CSF) induced apoptosis of murine myeloidleukemia cells
44. Isolation of islets from mice and rats
45. Differential promoter usage in prolactin receptor gene expression: Hepatocyte nuclear factor 4 binds to and activates the promoter preferentially active in the liver